| Financial Year |
March 31 2023 |
| Monetary Funds |
157,046,932.41 |
| Held-for-trading Financial Assets |
139,230,640.65 |
| Notes Receivable |
-- |
| Accounts Receivable |
105,195,212.87 |
| Advances to Suppliers |
8,120,582.76 |
| Other Receivables |
1,751,153.26 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
165,502,124.73 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,866,334.10 |
| Total Current Assets |
611,404,149.69 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
182,976,231.36 |
| Under-construction Projects |
253,034,423.12 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
66,725,648.97 |
| R&D expenses |
-- |
| Goodwill |
9,165,617.37 |
| Long-Term Deferred and Prepaid Expenses |
1,629,472.37 |
| Deferred Income Tax Assets |
8,689,690.95 |
| Other Non-Current Assets |
1,075,468.73 |
| Sub-Total of Non-Current Assets |
523,296,552.87 |
| Total Assets |
1,134,700,702.56 |
| Short-Term Loans |
87,038,316.67 |
| Trading Financial liabilities |
4,570,481.78 |
| Notes Payable |
5,897,383.39 |
| Accounts Payable |
82,381,662.97 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,353,095.76 |
| Taxes Payable |
2,058,278.46 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
13,093,114.13 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
731,908.17 |
| Other Current Liabilities |
55,782.18 |
| Sub-Total of Current Liabilities |
205,609,117.23 |
| Long-term Loans |
-- |
| Bonds Payable |
202,587,153.25 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,406,861.51 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
212,064,711.07 |
| Total Liabilities |
417,673,828.30 |
| Paid-In Capital(Or Share Stock) |
199,172,385.00 |
| Capital Surplus |
131,162,308.22 |
| Surplus Reserve |
27,186,161.35 |
| LESS:Treasury Stock |
12,554,944.00 |
| Undistributed Profits |
310,047,229.26 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
717,026,874.26 |
| Owner's Equity（Stockholder's Equity） |
717,026,874.26 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,134,700,702.56 |
